Cannabix Technologies Inc. (CSE: BLO), a developer of marijuana, multi-drug, and alcohol breath testing technologies, announces the detection of fentanyl in human breath samples collected using the Cannabix breath collection unit and breath cartridge technology and analyzed by Omega Laboratories Inc. utilizing liquid chromatography-mass spectrometry.
This article is a journalistic opinion piece that has been written based on independent research. It is intended to inform investors and should not be taken as a recommendation or financial advice.
Fentanyl is illegal and is a highly potent synthetic opioid associated with a growing public health and workplace safety crisis across North America. The identification of fentanyl in human breath demonstrates the ability of the standardized Cannabix breath collection unit, disposable breath cartridges, and associated laboratory-developed analytical methods, to capture and preserve measurable quantities of fentanyl from exhaled breath from a drug user.
Click here for the full story.
Top cannabis news stories
1 | MediPharm Labs reports Q3 2026 results with second consecutive quarter of positive net income and 18% sequential revenue growth
2 | Charlotte’s Web (TSX: CWEB) reports Total liabilities of US$19.4 million, down from US$77.3 million in December 2025
3 | Auxly (TSX: XLY) reports Q3 net revenue of C$49.5 million, an increase of 24%
Top Cannabis Stocks Nov. 06 to Nov. 13, 2026
1. T.CURA | 8,532 views | Curaleaf Holdings Inc.
2. T.TLRY | 6,338 views | Tilray Brands Inc.
3. T.ACB | 4,371 views | Aurora Cannabis Inc.
4. T.LABS| 3,396 views | Medipharm Labs Corp.
5. V.HIP | 2,256 views | Newstrike Brands Ltd.
6. T.APHA | 2,180 views | Aphria Inc.
Join the discussion: Find out what investors are saying about cannabis stocks and make sure to explore the rest of Stockhouse’s stock forums and message boards.
